This report contains market size and forecasts of Bio-pharma in global, including the following market information:
Global Bio-pharma Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global Bio-pharma Market Sales, 2016-2021, 2022-2027, (K Pcs)
Global top five Bio-pharma companies in 2020 (%)
The global Bio-pharma market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Bio-pharma manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Bio-pharma Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Pcs)
Global Bio-pharma Market Segment Percentages, By Type, 2020 (%)
Monoclonal Antibodies
Recombinant Proteins
Granulocyte-Colony Stimulating Factor (G-CSF)
Interferons
Recombinant Human Insulin
Erythropoietin
Vaccines
Growth Hormones
Purified Proteins
Others
Global Bio-pharma Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Pcs)
Global Bio-pharma Market Segment Percentages, By Application, 2020 (%)
Metabolic Disorders
Oncology
Neurological Disorders
Cardiovascular Diseases
Inflammatory and Infectious Diseases
Others
Global Bio-pharma Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions) & (K Pcs)
Global Bio-pharma Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Bio-pharma revenues in global market, 2016-2021 (Estimated), ($ millions)
Key companies Bio-pharma revenues share in global market, 2020 (%)
Key companies Bio-pharma sales in global market, 2016-2021 (Estimated), (K Pcs)
Key companies Bio-pharma sales share in global market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
F. Hoffmann-La Roche AG
Johnson & Johnson Services
Sanofi, Amgen
AbbVie
Merck & Co., Inc
Biogen Idec
Bayer AG
Eli Lilly and Company
Novartis AG GlaxoSmithKline Plc
Bristol-Myers Squibb Company
AstraZeneca PLC
Abbott Laboratories
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Bio-pharma Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Bio-pharma Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Bio-pharma Overall Market Size
2.1 Global Bio-pharma Market Size: 2021 VS 2027
2.2 Global Bio-pharma Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Bio-pharma Sales (Consumption): 2016-2027
3 Company Landscape
3.1 Top Bio-pharma Players in Global Market
3.2 Top Global Bio-pharma Companies Ranked by Revenue
3.3 Global Bio-pharma Revenue by Companies
3.4 Global Bio-pharma Sales by Companies
3.5 Global Bio-pharma Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Bio-pharma Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Bio-pharma Product Type
3.8 Tier 1, Tier 2 and Tier 3 Bio-pharma Players in Global Market
3.8.1 List of Global Tier 1 Bio-pharma Companies
3.8.2 List of Global Tier 2 and Tier 3 Bio-pharma Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Bio-pharma Market Size Markets, 2021 & 2027
4.1.2 Monoclonal Antibodies
4.1.3 Recombinant Proteins
4.1.4 Granulocyte-Colony Stimulating Factor (G-CSF)
4.1.5 Interferons
4.1.6 Recombinant Human Insulin
4.1.7 Erythropoietin
4.1.8 Vaccines
4.1.9 Growth Hormones
4.1.10 Purified Proteins
4.1.11 Others
4.2 By Type - Global Bio-pharma Revenue & Forecasts
4.2.1 By Type - Global Bio-pharma Revenue, 2016-2021
4.2.2 By Type - Global Bio-pharma Revenue, 2022-2027
4.2.3 By Type - Global Bio-pharma Revenue Market Share, 2016-2027
4.3 By Type - Global Bio-pharma Sales & Forecasts
4.3.1 By Type - Global Bio-pharma Sales, 2016-2021
4.3.2 By Type - Global Bio-pharma Sales, 2022-2027
4.3.3 By Type - Global Bio-pharma Sales Market Share, 2016-2027
4.4 By Type - Global Bio-pharma Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Bio-pharma Market Size, 2021 & 2027
5.1.2 Metabolic Disorders
5.1.3 Oncology
5.1.4 Neurological Disorders
5.1.5 Cardiovascular Diseases
5.1.6 Inflammatory and Infectious Diseases
5.1.7 Others
5.2 By Application - Global Bio-pharma Revenue & Forecasts
5.2.1 By Application - Global Bio-pharma Revenue, 2016-2021
5.2.2 By Application - Global Bio-pharma Revenue, 2022-2027
5.2.3 By Application - Global Bio-pharma Revenue Market Share, 2016-2027
5.3 By Application - Global Bio-pharma Sales & Forecasts
5.3.1 By Application - Global Bio-pharma Sales, 2016-2021
5.3.2 By Application - Global Bio-pharma Sales, 2022-2027
5.3.3 By Application - Global Bio-pharma Sales Market Share, 2016-2027
5.4 By Application - Global Bio-pharma Price (Manufacturers Selling Prices), 2016-2027
6 Sights by Region
6.1 By Region - Global Bio-pharma Market Size, 2021 & 2027
6.2 By Region - Global Bio-pharma Revenue & Forecasts
6.2.1 By Region - Global Bio-pharma Revenue, 2016-2021
6.2.2 By Region - Global Bio-pharma Revenue, 2022-2027
6.2.3 By Region - Global Bio-pharma Revenue Market Share, 2016-2027
6.3 By Region - Global Bio-pharma Sales & Forecasts
6.3.1 By Region - Global Bio-pharma Sales, 2016-2021
6.3.2 By Region - Global Bio-pharma Sales, 2022-2027
6.3.3 By Region - Global Bio-pharma Sales Market Share, 2016-2027
6.4 North America
6.4.1 By Country - North America Bio-pharma Revenue, 2016-2027
6.4.2 By Country - North America Bio-pharma Sales, 2016-2027
6.4.3 US Bio-pharma Market Size, 2016-2027
6.4.4 Canada Bio-pharma Market Size, 2016-2027
6.4.5 Mexico Bio-pharma Market Size, 2016-2027
6.5 Europe
6.5.1 By Country - Europe Bio-pharma Revenue, 2016-2027
6.5.2 By Country - Europe Bio-pharma Sales, 2016-2027
6.5.3 Germany Bio-pharma Market Size, 2016-2027
6.5.4 France Bio-pharma Market Size, 2016-2027
6.5.5 U.K. Bio-pharma Market Size, 2016-2027
6.5.6 Italy Bio-pharma Market Size, 2016-2027
6.5.7 Russia Bio-pharma Market Size, 2016-2027
6.5.8 Nordic Countries Bio-pharma Market Size, 2016-2027
6.5.9 Benelux Bio-pharma Market Size, 2016-2027
6.6 Asia
6.6.1 By Region - Asia Bio-pharma Revenue, 2016-2027
6.6.2 By Region - Asia Bio-pharma Sales, 2016-2027
6.6.3 China Bio-pharma Market Size, 2016-2027
6.6.4 Japan Bio-pharma Market Size, 2016-2027
6.6.5 South Korea Bio-pharma Market Size, 2016-2027
6.6.6 Southeast Asia Bio-pharma Market Size, 2016-2027
6.6.7 India Bio-pharma Market Size, 2016-2027
6.7 South America
6.7.1 By Country - South America Bio-pharma Revenue, 2016-2027
6.7.2 By Country - South America Bio-pharma Sales, 2016-2027
6.7.3 Brazil Bio-pharma Market Size, 2016-2027
6.7.4 Argentina Bio-pharma Market Size, 2016-2027
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Bio-pharma Revenue, 2016-2027
6.8.2 By Country - Middle East & Africa Bio-pharma Sales, 2016-2027
6.8.3 Turkey Bio-pharma Market Size, 2016-2027
6.8.4 Israel Bio-pharma Market Size, 2016-2027
6.8.5 Saudi Arabia Bio-pharma Market Size, 2016-2027
6.8.6 UAE Bio-pharma Market Size, 2016-2027
7 Manufacturers & Brands Profiles
7.1 Pfizer
7.1.1 Pfizer Corporate Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Bio-pharma Major Product Offerings
7.1.4 Pfizer Bio-pharma Sales and Revenue in Global (2016-2021)
7.1.5 Pfizer Key News
7.2 F. Hoffmann-La Roche AG
7.2.1 F. Hoffmann-La Roche AG Corporate Summary
7.2.2 F. Hoffmann-La Roche AG Business Overview
7.2.3 F. Hoffmann-La Roche AG Bio-pharma Major Product Offerings
7.2.4 F. Hoffmann-La Roche AG Bio-pharma Sales and Revenue in Global (2016-2021)
7.2.5 F. Hoffmann-La Roche AG Key News
7.3 Johnson & Johnson Services
7.3.1 Johnson & Johnson Services Corporate Summary
7.3.2 Johnson & Johnson Services Business Overview
7.3.3 Johnson & Johnson Services Bio-pharma Major Product Offerings
7.3.4 Johnson & Johnson Services Bio-pharma Sales and Revenue in Global (2016-2021)
7.3.5 Johnson & Johnson Services Key News
7.4 Sanofi, Amgen
7.4.1 Sanofi, Amgen Corporate Summary
7.4.2 Sanofi, Amgen Business Overview
7.4.3 Sanofi, Amgen Bio-pharma Major Product Offerings
7.4.4 Sanofi, Amgen Bio-pharma Sales and Revenue in Global (2016-2021)
7.4.5 Sanofi, Amgen Key News
7.5 AbbVie
7.5.1 AbbVie Corporate Summary
7.5.2 AbbVie Business Overview
7.5.3 AbbVie Bio-pharma Major Product Offerings
7.5.4 AbbVie Bio-pharma Sales and Revenue in Global (2016-2021)
7.5.5 AbbVie Key News
7.6 Merck & Co., Inc
7.6.1 Merck & Co., Inc Corporate Summary
7.6.2 Merck & Co., Inc Business Overview
7.6.3 Merck & Co., Inc Bio-pharma Major Product Offerings
7.6.4 Merck & Co., Inc Bio-pharma Sales and Revenue in Global (2016-2021)
7.6.5 Merck & Co., Inc Key News
7.7 Biogen Idec
7.7.1 Biogen Idec Corporate Summary
7.7.2 Biogen Idec Business Overview
7.7.3 Biogen Idec Bio-pharma Major Product Offerings
7.4.4 Biogen Idec Bio-pharma Sales and Revenue in Global (2016-2021)
7.7.5 Biogen Idec Key News
7.8 Bayer AG
7.8.1 Bayer AG Corporate Summary
7.8.2 Bayer AG Business Overview
7.8.3 Bayer AG Bio-pharma Major Product Offerings
7.8.4 Bayer AG Bio-pharma Sales and Revenue in Global (2016-2021)
7.8.5 Bayer AG Key News
7.9 Eli Lilly and Company
7.9.1 Eli Lilly and Company Corporate Summary
7.9.2 Eli Lilly and Company Business Overview
7.9.3 Eli Lilly and Company Bio-pharma Major Product Offerings
7.9.4 Eli Lilly and Company Bio-pharma Sales and Revenue in Global (2016-2021)
7.9.5 Eli Lilly and Company Key News
7.10 Novartis AG GlaxoSmithKline Plc
7.10.1 Novartis AG GlaxoSmithKline Plc Corporate Summary
7.10.2 Novartis AG GlaxoSmithKline Plc Business Overview
7.10.3 Novartis AG GlaxoSmithKline Plc Bio-pharma Major Product Offerings
7.10.4 Novartis AG GlaxoSmithKline Plc Bio-pharma Sales and Revenue in Global (2016-2021)
7.10.5 Novartis AG GlaxoSmithKline Plc Key News
7.11 Bristol-Myers Squibb Company
7.11.1 Bristol-Myers Squibb Company Corporate Summary
7.11.2 Bristol-Myers Squibb Company Bio-pharma Business Overview
7.11.3 Bristol-Myers Squibb Company Bio-pharma Major Product Offerings
7.11.4 Bristol-Myers Squibb Company Bio-pharma Sales and Revenue in Global (2016-2021)
7.11.5 Bristol-Myers Squibb Company Key News
7.12 AstraZeneca PLC
7.12.1 AstraZeneca PLC Corporate Summary
7.12.2 AstraZeneca PLC Bio-pharma Business Overview
7.12.3 AstraZeneca PLC Bio-pharma Major Product Offerings
7.12.4 AstraZeneca PLC Bio-pharma Sales and Revenue in Global (2016-2021)
7.12.5 AstraZeneca PLC Key News
7.13 Abbott Laboratories
7.13.1 Abbott Laboratories Corporate Summary
7.13.2 Abbott Laboratories Bio-pharma Business Overview
7.13.3 Abbott Laboratories Bio-pharma Major Product Offerings
7.13.4 Abbott Laboratories Bio-pharma Sales and Revenue in Global (2016-2021)
7.13.5 Abbott Laboratories Key News
8 Global Bio-pharma Production Capacity, Analysis
8.1 Global Bio-pharma Production Capacity, 2016-2027
8.2 Bio-pharma Production Capacity of Key Manufacturers in Global Market
8.3 Global Bio-pharma Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Bio-pharma Supply Chain Analysis
10.1 Bio-pharma Industry Value Chain
10.2 Bio-pharma Upstream Market
10.3 Bio-pharma Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Bio-pharma Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
List of Tables
Table 1. Key Players of Bio-pharma in Global Market
Table 2. Top Bio-pharma Players in Global Market, Ranking by Revenue (2019)
Table 3. Global Bio-pharma Revenue by Companies, (US$, Mn), 2016-2021
Table 4. Global Bio-pharma Revenue Share by Companies, 2016-2021
Table 5. Global Bio-pharma Sales by Companies, (K Pcs), 2016-2021
Table 6. Global Bio-pharma Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Bio-pharma Price (2016-2021) & (USD/Pcs)
Table 8. Global Manufacturers Bio-pharma Product Type
Table 9. List of Global Tier 1 Bio-pharma Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Bio-pharma Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type